FANCD2 and cancer: Figure 6A shows the comparison between the primary and recurrent tumor groups in the NMIBC patient groups. The results showed that the expression of these genes was significantly higher in recurrent cancer tissues than it was in primary cancer tissues (p = 0.004; FOXM1 and p = 0.001; FANCD2 by two sample t-test, Figure 6A).